Dr. Weaver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3000 Medical Park Dr
Ste 250
Tampa, FL 33613Phone+1 813-632-6220Fax+1 813-971-5893
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2003 - 2006
- University of South Florida MorsaniResidency, Internal Medicine, 2000 - 2003
- University of South Florida College of MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2003 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Publications & Presentations
PubMed
- 126 citationsEMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast CancerDenise A. Yardley, Robert Weaver, Michelle E. Melisko, Mansoor N. Saleh, Francis P. Arena
Journal of Clinical Oncology. 2015-05-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: